Cyclin-Dependent Kinase Inhibitor p27 Kip1 , But Not p21 WAF1/Cip1 , Is Required for Inhibition of Hypoxia-Induced Pulmonary Hypertension and Remodeling by Heparin in Mice
Author:
Affiliation:
1. From the Department of Medicine, Pulmonary and Critical Care Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine,Physiology
Reference44 articles.
1. The Origin of the Dispute over the Discovery of Heparin
2. Garg HG Roughley PJ Hales CA. Proteoglycans in Lung Disease. In: Garg HG Hales CA and Linhardt RJ eds. Heparin as a Potential Therapeutic Agent to Reverse Vascular Remodeling. New York NY: Marcel Dekker Inc; 2002: 377–398.
3. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension
4. Rabinovitch M. Pulmonary vascular remodeling in hypoxic pulmonary hypertension. In: Yuan J X-J. ed. Hypoxic Pulmonary Vasoconstriction: Cellular and Molecular Mechanisms. Norwell Mass: Kluwer Academic Publishers; 2004: 403–418.
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Loss of prolyl hydroxylase 1 and 2 in SM22α-expressing cells prevents Hypoxia-Induced pulmonary hypertension;American Journal of Physiology-Lung Cellular and Molecular Physiology;2023-12-01
2. The Effect of Mechanical Stress on Hyaluronan Fragments’ Inflammatory Cascade: Clinical Implications;Life;2023-11-29
3. Pathogenic mechanisms and therapeutic implications of extracellular matrix remodelling in cerebral vasospasm;Fluids and Barriers of the CNS;2023-11-04
4. Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension;Pulmonary Circulation;2021-07
5. Beyond the genome: challenges and potential for epigenetics-driven therapeutic approaches in pulmonary arterial hypertension;Biochemistry and Cell Biology;2020-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3